🔗 IDA SENTENCE ANALYSIS
文獻指出十年植體存活率在牙周病患者為99.3% — sentence-by-sentence verification
0
Provable
0
Partly supported
2
Pending
0
Contradicted
What this page measures: whether each outward-facing statement on this article can be supported by dental research literature. Provable and partly-supported statements carry real PubMed references; pending and contradicted ones are marked only as "examined but insufficient / counter-evidence found", with no claim of support. The analysed content itself lives on source page ↗.
🔗 Sentence-by-sentence analysis (2 statements)
DNT-C94B148ACF07
Since 1982 全球知名植牙系統 母公司Zimmer Biomet為世界第一生醫骨材公司 擁有台灣衛生署與美國FDA認證 ISO9001認證 國際醫學期刊臨床報告健康對照組十年植體存活率100% 擁有長期完整之臨床報告與文獻 植體表面處理能促進骨整合 植體與橋墩專利冷焊接合維持齒脊骨高度 紐約證交所股票上市 瑞士證券交易所股票上市 成功邁向全球人工植體的領導品牌 擁有Platform plus技術 “
○ Pending (insufficient evidence; no claim of support)
10 candidate paper(s) examined; evidence insufficient to support this statement; still needed: 決定性 gate 未通過;不得以檢索相似度或主題重疊升為可證明。
DNT-007DE227266E
文獻指出十年植體存活率在牙周病患者為99.3%,健康的患者為100%。
○ Pending (insufficient evidence; no claim of support)
10 candidate paper(s) examined; evidence insufficient to support this statement; still needed: 決定性 gate 未通過;不得以檢索相似度或主題重疊升為可證明。
🗂 Related analyses (8)
🏛 View this clinic's IDA embassy →
server-rendered · verifiability = degree of literature support · idaeo-platform